A handful of discovered-in-China candidates have entered the global clinic, including a few first-in-class contenders.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Mullard, A. Chinese biopharma starts feeding the global pipeline. Nat Rev Drug Discov 16, 443–446 (2017). https://doi.org/10.1038/nrd.2017.94
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.94
- Springer Nature Limited
This article is cited by
-
Trends and Characteristics of New Drug Approvals in China, 2011–2021
Therapeutic Innovation & Regulatory Science (2023)
-
Novel Drugs Targeting the Epigenome
Current Pharmacology Reports (2017)